Naohiko Seki - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Naohiko Seki - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2002	6
2003	9
2004	7
2005	9
2006	11
2007	11
2008	7
2009	5
2010	7
2011	19
2012	19
2013	16
2014	16
2015	13
2016	22
2017	23
2018	19
2019	13
2020	9
2021	11
2022	7
2023	8
2024	1

230 results

Page of 23

Results by year

Page 1

Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma.

Kasamatsu A, Nozaki R, Kawasaki K, Saito T, Minemura C, Seki N, Moss J, Uzawa K. Kasamatsu A, et al. Among authors: seki n. Cancers (Basel). 2024 Mar 21;16(6):1242. doi: 10.3390/cancers16061242. Cancers (Basel). 2024. PMID: 38539573 Free PMC article.

Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.

Kurozumi S, Seki N, Narusawa E, Honda C, Tokuda S, Nakazawa Y, Yokobori T, Katayama A, Mongan NP, Rakha EA, Oyama T, Fujii T, Shirabe K, Horiguchi J. Kurozumi S, et al. Among authors: seki n. Int J Mol Sci. 2023 Dec 19;25(1):35. doi: 10.3390/ijms25010035. Int J Mol Sci. 2023. PMID: 38203206 Free PMC article.

Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma.

Hagihara Y, Tomioka Y, Suetsugu T, Shinmura M, Misono S, Goto Y, Kikkawa N, Kato M, Inoue H, Mizuno K, Seki N. Hagihara Y, et al. Among authors: seki n. Cancers (Basel). 2023 Nov 24;15(23):5571. doi: 10.3390/cancers15235571. Cancers (Basel). 2023. PMID: 38067275 Free PMC article.

Oncogenic Targets Regulated by Tumor-Suppressive miR-30c-1-3p and miR-30c-2-3p: TRIP13 Facilitates Cancer Cell Aggressiveness in Breast Cancer.

Mitsueda R, Toda H, Shinden Y, Fukuda K, Yasudome R, Kato M, Kikkawa N, Ohtsuka T, Nakajo A, Seki N. Mitsueda R, et al. Among authors: seki n. Cancers (Basel). 2023 Aug 21;15(16):4189. doi: 10.3390/cancers15164189. Cancers (Basel). 2023. PMID: 37627217 Free PMC article.

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets.

Tanigawa K, Tomioka Y, Misono S, Asai S, Kikkawa N, Hagihara Y, Suetsugu T, Inoue H, Mizuno K, Seki N. Tanigawa K, et al. Among authors: seki n. FEBS Open Bio. 2023 Sep;13(9):1737-1755. doi: 10.1002/2211-5463.13681. Epub 2023 Aug 7. FEBS Open Bio. 2023. PMID: 37517032 Free PMC article.

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma.

Tomioka Y, Suetsugu T, Seki N, Tanigawa K, Hagihara Y, Shinmura M, Asai S, Kikkawa N, Inoue H, Mizuno K. Tomioka Y, et al. Among authors: seki n. Cells. 2023 Jul 18;12(14):1885. doi: 10.3390/cells12141885. Cells. 2023. PMID: 37508549 Free PMC article.

Coronin 1C, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma.

Fukuda K, Seki N, Yasudome R, Mitsueda R, Asai S, Kato M, Idichi T, Kurahara H, Ohtsuka T. Fukuda K, et al. Among authors: seki n. Genes (Basel). 2023 Apr 27;14(5):995. doi: 10.3390/genes14050995. Genes (Basel). 2023. PMID: 37239355 Free PMC article.

MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.

Asai S, Goto Y, Tanigawa K, Tomioka Y, Kato M, Mizuno K, Sakamoto S, Seki N. Asai S, et al. Among authors: seki n. FEBS Lett. 2023 Apr;597(8):1164-1175. doi: 10.1002/1873-3468.14598. Epub 2023 Feb 20. FEBS Lett. 2023. PMID: 36754848 Free article.

MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.

Tanigawa K, Misono S, Mizuno K, Asai S, Suetsugu T, Uchida A, Kawano M, Inoue H, Seki N. Tanigawa K, et al. Among authors: seki n. Mol Oncol. 2023 Feb;17(2):328-343. doi: 10.1002/1878-0261.13339. Epub 2022 Nov 23. Mol Oncol. 2023. PMID: 36345848 Free PMC article.

MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway.

Aersilan A, Hashimoto N, Yamagata K, Yokoyama M, Nakayama A, Shi X, Nagano H, Sakuma I, Nohata N, Kinoshita T, Seki N, Rahmutulla B, Kaneda A, Zhahara SN, Gong Y, Nishimura M, Kawauchi S, Kawakami E, Tanaka T. Aersilan A, et al. Among authors: seki n. Sci Rep. 2022 Nov 2;12(1):18443. doi: 10.1038/s41598-022-23205-w. Sci Rep. 2022. PMID: 36323841 Free PMC article.

230 results

Page of 23

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

230 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year